The Egyptian Drug Authority unveils an ambitious strategy to develop the medical sector by 2030
The activities of the fifth edition of the Africa Health ExCon 2026 featured a comprehensive overview of the future of the pharmaceutical sector in Egypt. The Chairman of the Egyptian Drug Authority announced the launch of an ambitious national strategy aimed at developing the pharmaceutical industries in the country by 2030.
This new strategy is based on five main pillars aimed at strengthening Egypt's position as a leading regional hub in the pharmaceutical field. Through this plan, officials seek to support and grow the Egyptian pharmaceutical market, which is currently valued at approximately 8.5 billion US dollars, making it one of the largest pharmaceutical markets in the region.
The Authority's future plans include focusing on increasing investments in local manufacturing, streamlining drug registration procedures, and enhancing cooperation with African countries. These efforts aim to provide high-quality medicines to Egyptian citizens at affordable prices while ensuring the availability of a strategic stockpile of essential medical products.
This announcement comes at a time when the Egyptian state is placing great importance on localizing the pharmaceutical industry and reducing reliance on imports. It is expected that this strategy will contribute to creating new job opportunities for young people in the medical sector and supporting the national economy by increasing pharmaceutical exports to global and African markets.
In conclusion, this international medical conference reflects Egypt's keenness to exchange expertise with international partners and develop health infrastructure. These steps are part of a broader vision aimed at improving the quality of health services provided to citizens and developing medical technology in Egypt over the coming years.